W L Carroll
Overview
Explore the profile of W L Carroll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Salzer W, Devidas M, Carroll W, Winick N, Pullen J, Hunger S, et al.
Leukemia
. 2009 Dec;
24(2):355-70.
PMID: 20016527
From 1984 to 2001, the Pediatric Oncology Group (POG) conducted 12 acute lymphoblastic leukemia (ALL) studies. Ten-year event-free survival (EFS) for patients >12 months of age with B-precursor ALL on...
12.
Hijiya N, Gaynon P, Barry E, Silverman L, Thomson B, Chu R, et al.
Leukemia
. 2009 Sep;
23(12):2259-64.
PMID: 19741725
This Phase I study of clofarabine with etoposide and cyclophosphamide for children with relapsed/refractory acute lymphoblastic leukemia (ALL) or acute myelogenous leukemia (AML) was conducted to determine the maximum tolerated...
13.
Nguyen K, Devidas M, Cheng S, La M, Raetz E, Carroll W, et al.
Leukemia
. 2008 Sep;
22(12):2142-50.
PMID: 18818707
Despite great progress in curing childhood acute lymphoblastic leukemia (ALL), survival after relapse remains poor. We analyzed survival after relapse among 9585 pediatric patients enrolled on Children's Oncology Group clinical...
14.
Eapen M, Zhang M, Devidas M, Raetz E, Barredo J, Ritchey A, et al.
Leukemia
. 2007 Nov;
22(2):281-6.
PMID: 18033318
In children with acute lymphoblastic leukemia (ALL) with isolated central nervous system (CNS) relapse and a human leucocyte antigen (HLA)-matched sibling, the optimal treatment after attaining second remission is unknown....
15.
Szabo A, Boucher K, Carroll W, Klebanov L, Tsodikov A, Yakovlev A
Math Biosci
. 2002 Feb;
176(1):71-98.
PMID: 11867085
Lack of adequate statistical methods for the analysis of microarray data remains the most critical deterrent to uncovering the true potential of these promising techniques in basic and translational biological...
16.
Liu T, Raetz E, Moos P, Perkins S, Bruggers C, Smith F, et al.
Leukemia
. 2002 Feb;
16(2):223-32.
PMID: 11840289
Apoptosis is the primary mechanism through which most chemotherapeutic agents induce tumor cell death. The purpose of this study was to determine the extent to which blasts from children with...
17.
Raetz E, Moos P, Szabo A, Carroll W
Hematol Oncol Clin North Am
. 2002 Jan;
15(5):911-30, ix.
PMID: 11765379
The advent of microarray technology undoubtedly will have great impact on the medical field during the next decade. This article discusses different genomic technologies, statistical methods for data analysis, and...
18.
Tai K, ROGERS S, Pont-Kingdon G, Carroll W
Pediatr Res
. 1999 Sep;
46(3):255-62.
PMID: 10473038
The N-myc oncogene directs organogenesis, and gene amplification is associated with aggressive forms of neuroblastoma, a common malignant tumor in children. N-myc is expressed in fetal epithelium, and expression decreases...
19.
Bruggers C, Fults D, Perkins S, Coffin C, Carroll W
J Pediatr Hematol Oncol
. 1999 Feb;
21(1):19-25.
PMID: 10029807
Purpose: Apoptosis plays a crucial role in normal development and mediates tumor response to chemotherapy. This study investigated the pattern of apoptotic gene expression in brain tumor tissue specimens and...
20.
Sivak L, Pont-Kingdon G, Le K, Mayr G, Tai K, Stevens B, et al.
Mol Cell Biol
. 1998 Dec;
19(1):155-63.
PMID: 9858540
Precisely regulated expression of oncogenes and tumor suppressor genes is essential for normal development, and deregulated expression can lead to cancer. The human N-myc gene normally is expressed in only...